Nelson Cabatuan is the Chief Finance Officer at Rain Therapeutics. He has over 20 years of experience in building and optimizing processes in accounting and finance, financial planning and analysis, research and development, commercial launch and regulatory compliance-related processes and operations. Prior to joining Rain he was VP of Finance and Principal Accounting Officer at Rigel Pharmaceuticals, where he was a key player in fundraising initiatives of over $1B in follow on public offerings for the company. Before Rigel he was a Senior Manager in Audit and Transaction Advisory Services at Grant Thornton LLP where he provided assurance and advisory services to private and public companies from pre-IPO to large public global companies. Prior to Grant Thornton LLP, he worked in Audit and Advisory Services and Business Advisory Services at Ernst & Young Philippines where he served as an engagement manager in external and internal audits of private and public clients.
Nelson graduated with a Bachelor of Science in Accountancy from the University of the City of Manila in the Philippines, and holds professional certifications as a Certified Public Account (CA & Philippines), Certified Fraud Examiner, and a Certified Internal Auditor.